Jove
Visualize
Contact Us

Related Experiment Videos

Development of bisphosphonates.

Herbert Fleisch

    Breast Cancer Research : BCR
    |March 7, 2002
    PubMed
    Summary
    This summary is machine-generated.

    Bisphosphonates inhibit bone resorption by affecting osteoclast cells. Nitrogen-containing bisphosphonates disrupt the mevalonate pathway, while others form non-hydrolyzable ATP analogs, leading to osteoclast apoptosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    Visceral adiposity and breast cancer outcomes: transcriptomic analysis of the tumor microenvironment by intrinsic subtype.

    Breast cancer research : BCR·2026
    Same journal

    Development and validation of an immune-related molecular subtyping model based on a four-gene prognostic biomarker signature and multi-omics integrative analysis in Luminal B breast cancer.

    Breast cancer research : BCR·2026
    Same journal

    LMAN2 promotes breast cancer progression and deduces cell sensitivity to doxorubicin through stearoyl-CoA desaturase.

    Breast cancer research : BCR·2026
    Same journal

    Postpartum breast cancer as a distinct oncologic entity: linking physiological tissue remodelling to tumor biology and clinical translation.

    Breast cancer research : BCR·2026
    Same journal

    H-score and ERBB2 mRNA refine identification of HER2-low and HER2-ultralow breast cancer.

    Breast cancer research : BCR·2026
    Same journal

    Serum perfluoroalkyl substances (PFASs) concentrations and associations with mammographic density in postmenopausal women.

    Breast cancer research : BCR·2026
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Biochemistry
    • Pharmacology
    • Cell Biology

    Background:

    • Bisphosphonates are synthetic P-C-P compounds, pyrophosphate analogs.
    • Historically used in industry, biological effects recognized in 1968.
    • Key medical uses include osteoporosis and Paget's disease treatment.

    Purpose of the Study:

    • To elucidate the cellular and biochemical mechanisms of bisphosphonate action.
    • To differentiate mechanisms between nitrogen-containing and other bisphosphonates.
    • To explain bisphosphonate-induced inhibition of bone resorption and calcification.

    Main Methods:

    • Review of existing literature on bisphosphonate mechanisms.
    • Analysis of cellular effects on osteoclasts (apoptosis, cytoskeleton).

    Related Experiment Videos

  • Biochemical investigation of the mevalonate pathway and ATP analog formation.

    • Main Results:

    • Bisphosphonates inhibit bone resorption via osteoclast apoptosis and cytoskeleton disruption.
    • Nitrogen-containing bisphosphonates inhibit farnesylpyrophosphate synthase in the mevalonate pathway.
    • Other bisphosphonates form non-hydrolyzable ATP analogs, impairing cell function.

    Conclusions:

    • Bisphosphonates exert cellular effects leading to osteoclast dysfunction and apoptosis.
    • Distinct biochemical pathways are targeted by different classes of bisphosphonates.
    • Understanding these mechanisms is crucial for optimizing osteoporosis and related bone disease treatments.